ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Scientists at Tokyo's Keio University use a cell processing isolator to ensure a sterile environment. (Photo by Ken Kobayashi)
The Big Story

Japan faces new competition in the race for 'regenerative medicine'

Promising iPS cell technology could lead to breakthroughs in Parkinson's disease, blindness and paralysis

KIYOSHI ANDO, Nikkei senior staff writer | Japan

TOKYO -- Masaya Nakamura can pinpoint the moment when he decided to dedicate his life to researching and treating spinal cord injuries. It was during his second year at Keio University, and he and some other students had taken a skiing trip near Nagano. One of his friends crashed into a tree at high speed, leaving him paralyzed from the neck down. Nakamura had been studying to become a doctor but was undecided about what type of medicine he wanted to practice -- until then. "For more than 20 years, my motivation has been to cure my friend's spinal cord injury," he said.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more